238 related articles for article (PubMed ID: 32546741)
1. The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor.
Ouyang L; Yan B; Liu Y; Mao C; Wang M; Liu N; Wang Z; Liu S; Shi Y; Chen L; Wang X; Cheng Y; Cao Y; Xiao D; Zhang L; Liu S; Tao Y
Signal Transduct Target Ther; 2020 Jun; 5(1):78. PubMed ID: 32546741
[TBL] [Abstract][Full Text] [Related]
2. LINC00665 knockdown confers sensitivity in irradiated non-small cell lung cancer cells through the miR-582-5p/UCHL3/AhR axis.
Xu LM; Yuan YJ; Yu H; Wang S; Wang P
J Transl Med; 2022 Aug; 20(1):350. PubMed ID: 35918714
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway.
Tang J; Yang Q; Mao C; Xiao D; Liu S; Xiao L; Zhou L; Wu G; Tao Y
Cell Death Differ; 2023 May; 30(5):1247-1259. PubMed ID: 36813921
[TBL] [Abstract][Full Text] [Related]
5. Activation of AhR with nuclear IKKα regulates cancer stem-like properties in the occurrence of radioresistance.
Yan B; Liu S; Shi Y; Liu N; Chen L; Wang X; Xiao D; Liu X; Mao C; Jiang Y; Lai W; Xin X; Tang CE; Luo D; Tan T; Jia J; Liu Y; Yang R; Huang J; Zhou H; Cheng Y; Cao Y; Yu W; Muegge K; Tao Y
Cell Death Dis; 2018 May; 9(5):490. PubMed ID: 29706625
[TBL] [Abstract][Full Text] [Related]
6. Role of AhR in regulating cancer stem cell-like characteristics in choriocarcinoma.
Wu C; Yu S; Tan Q; Guo P; Liu H
Cell Cycle; 2018; 17(18):2309-2320. PubMed ID: 30311543
[TBL] [Abstract][Full Text] [Related]
7.
Das B; Pal B; Bhuyan R; Li H; Sarma A; Gayan S; Talukdar J; Sandhya S; Bhuyan S; Gogoi G; Gouw AM; Baishya D; Gotlib JR; Kataki AC; Felsher DW
Cancer Res; 2019 Aug; 79(16):4015-4025. PubMed ID: 31266772
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
9. Silencing UCHL3 enhances radio-sensitivity of non-small cell lung cancer cells by inhibiting DNA repair.
Liu M; Chen H; Chen X; Xiong J; Song Z
Aging (Albany NY); 2021 May; 13(10):14277-14288. PubMed ID: 34016790
[TBL] [Abstract][Full Text] [Related]
10. UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells.
Long G; Wu Z; Wang D; Mi X; Hu K; Zhou L; Tang J
Free Radic Biol Med; 2024 Feb; 212():162-173. PubMed ID: 38092274
[TBL] [Abstract][Full Text] [Related]
11. Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4.
Lee CC; Yang WH; Li CH; Cheng YW; Tsai CH; Kang JJ
Cancer Lett; 2016 Jul; 376(2):211-7. PubMed ID: 27060206
[TBL] [Abstract][Full Text] [Related]
12. N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
Wang Y; Zhou Y; Tao F; Chai S; Xu X; Yang Y; Yang Y; Xu H; Wang K
Cancer Lett; 2017 Aug; 401():53-62. PubMed ID: 28456659
[TBL] [Abstract][Full Text] [Related]
13. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.
Stanford EA; Wang Z; Novikov O; Mulas F; Landesman-Bollag E; Monti S; Smith BW; Seldin DC; Murphy GJ; Sherr DH
BMC Biol; 2016 Mar; 14():20. PubMed ID: 26984638
[TBL] [Abstract][Full Text] [Related]
14. ALK
Xu BS; Chen HY; Que Y; Xiao W; Zeng MS; Zhang X
Oncogene; 2020 Jan; 39(1):151-163. PubMed ID: 31462708
[TBL] [Abstract][Full Text] [Related]
15. UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway.
Zhang MH; Zhang HH; Du XH; Gao J; Li C; Shi HR; Li SZ
Oncogene; 2020 Jan; 39(2):322-333. PubMed ID: 31477831
[TBL] [Abstract][Full Text] [Related]
16. Calcium channel α2δ1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer.
Ma Y; Yang X; Zhao W; Yang Y; Zhang Z
Cell Death Dis; 2021 Mar; 12(3):257. PubMed ID: 33707423
[TBL] [Abstract][Full Text] [Related]
17. Stemness and anti-cancer drug resistance in ATP-binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions.
Sasaki N; Ishiwata T; Hasegawa F; Michishita M; Kawai H; Matsuda Y; Arai T; Ishikawa N; Aida J; Takubo K; Toyoda M
Cancer Sci; 2018 Apr; 109(4):1135-1146. PubMed ID: 29444383
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling.
Ye M; Zhang Y; Gao H; Xu Y; Jing P; Wu J; Zhang X; Xiong J; Dong C; Yao L; Zhang J; Zhang J
Clin Cancer Res; 2018 Mar; 24(5):1227-1239. PubMed ID: 29229632
[No Abstract] [Full Text] [Related]
19. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
Gentil M; Hugues P; Desterke C; Telliam G; Sloma I; Souza LEB; Baykal S; Artus J; Griscelli F; Guerci A; Johnson-Ansah H; Foudi A; Bennaceur-Griscelli A; Turhan AG
PLoS One; 2018; 13(8):e0200923. PubMed ID: 30091999
[TBL] [Abstract][Full Text] [Related]
20. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
